David C. Marek is CEO at Myovant Sciences Ltd. (MYOV). They have made 5 open-market trades across 1 company since 2022, most recently 2023-03-10.
CIK 0001556914
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYOV | SELL | 2023-01-18 | 2023-01-20 | $26.89 | $432K | +0.0% | +0.1% | N/A |
| MYOV | SELL | 2022-10-18 | 2022-10-20 | $25.20 | $562K | +10.3% | +10.3% | +10.7% |
| MYOV | SELL | 2022-07-18 | 2022-07-20 | $12.87 | $287K | +8.2% | +43.2% | +99.8% |
| MYOV | SELL | 2022-04-19 | 2022-04-21 | $10.45 | $514K | +7.3% | +9.3% | +29.9% |
| MYOV | SELL | 2022-01-19 | 2022-01-21 | $14.68 | $584K | -4.5% | -7.3% | -27.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.